Press Releases

Page Category: 

Sonosite Solutions provides a ready-made, but highly modifiable and scalable, clinical pathway to reduce CVC-insertion complications through the use of point-of-care ultrasound

BOTHELL, WA, May 13, 2014 – FUJIFILM Sonosite Inc. , the world leader and pioneering specialist in bedside and point-of-care ultrasound, announced the availability of a new patient-safety program designed to help hospitals reduce complications during CVC insertion. The Sonosite Solution for Safer Central Venous Catheter Insertion includes a guidebook and resource center that provides healthcare professionals with practice guidelines, procedure protocols, key metrics for benchmark success, educational videos and more. Most importantly, a team of Solutions Advisors support the program and help clinicians and administrators at participating institutions navigate through the wealth of available information.

"Central Venous Catheter (CVC) insertion can be risky. Both mechanical complications, such as a pneumothorax, or a Central Line-Associated Blood Stream Infection (CLABSI) can occur during the procedure,” said Diku Mandavia, MD, Senior Vice President and Chief Medical Officer at FUJIFILM Sonosite, Inc. “An iatrogenic pneumothorax is deemed a high cost and preventable event at many hospitals and healthcare systems and, as of October 2012, the Center for Medicare and Medicaid Services (CMS) will not compensate hospitals for additional costs incurred from this complication."

New open-access VividTrac® device—for “where you need it, when you need it” intubation— brings video intubation to the forefront of patient care

BOTHELL, WA, January 14, 2014 – FUJIFILM Sonosite, Inc. , the world leader and pioneering specialist in bedside and point-of-care ultrasound, today announced a partnership with Vivid Medical Inc. of Palo Alto, CA, to co-promote the VividTrac® Video Intubation Device. VividTrac is the world’s first and only single-use, "open access” video intubation device with a USB interface that connects easily to a variety of display options. By simply plugging the VividTrac device into a compatible system, clinicians will have access to high-resolution video intubation to enhance patient safety and care.

Sonosite's X-Porte™ Ultrasound Kiosk integrates advanced signal processing for high-resolution imaging, 3D animated clinical guides, and a cutting-edge multi-gesture user interface—all first-ever innovations in point-of-care ultrasound

BOTHELL, WA – November 8, 2013 – FUJIFILM Sonosite, Inc. , specialists in designing cutting-edge ultrasound tools and world-leading education for access to point-of-care visualization, today announced it received 510(k) clearance from the FDA for its newest generation of point-of-care ultrasound: the X-Porte™ Ultrasound Kiosk . Available in a stationary or a detachable use model, Sonosite will begin shipping the X-Porte kiosk in the United States effective immediately. The X-Porte is already available in parts of Europe and Asia-Pacific.

"This is a major accomplishment for Sonosite and a defining moment in the next phase of our innovation strategy," says Sonosite President and CEO Kevin M. Goodwin. "Working side-by-side with hundreds of clinicians from the frontlines of medicine worldwide, we combined their many insights with the most innovative consumer technologies available today. Then, we blended in our own inspiration from key engineers at our company, creating a remarkable new tool built from the ground up."

BOTHELL, WA– December 13, 2012- FUJIFILM Sonosite, Inc. , the world leader and specialist in bedside and point-of-care ultrasound, recognizes Life Line Screening for providing access to preventive screening services and encouraging millions of people to take a proactive approach to their health. With point-of-care ultrasound visualization, Life Line Screenings' clinicians are able to look inside a patient’s body to identify disease that could otherwise remain asymptomatic and undetected. As a leading provider of community based preventive health screening events for almost 20 years, Life Line Screening has administered over seven million screenings.

Introducing a New Care Path Strategy to Reduce Complications and Costs

Ultrasound-Guided Peripheral IVs Replace High-Risk Central Venous Catheter Line Placements in 84% of Patients

BOTHELL, WA– November 8, 2012– FUJIFILM Sonosite, Inc., the world leader and specialist in bedside and point-of-care ultrasound, announces new patient safety data achieved by Thomas Jefferson University Hospitals, Inc. (TJUH), a 957-bed academic medical center located in Philadelphia. Arthur Au, MD, a Clinical Instructor at Jefferson Medical College and Emergency Medicine physician at TJUH presented new data from an internal ultrasound-guidance study at the 2011 American College of Emergency Physicians (ACEP) conference.

Discovering a New Care Path Strategy

The goal of the study at TJUH was to determine if the number of Central Venous Catheter (CVC) placements could be reduced or replaced with a safer alternative− ultrasound-guided peripheral intravenous (USGPIVs) in patients with difficult IV access. The clinical challenge with most patients entering the emergency department includes: obesity, edema, or small veins that are difficult to visualize, making it incredibly difficult for a physician or nurse to place a peripheral IV.

New needle guidance solution helps make central venous catheter procedures "point-and-shoot" simple to improve care quality and reduce healthcare costs

BOTHELL, WA (September 13, 2012) – Sonosite, Inc., a subsidiary of FUJIFILM Corporation and the world leader and specialist in bedside and point-of-care ultrasound, today announced a partnership with Soma Access Systems LLC to bring AxoTrack™ needle visualization technology to market on Sonosite ultrasound systems. This innovative technology combines traditional ultrasound imaging with advanced magnetics to provide clinicians with a real-time update of the needle position that can be visualized as it travels through tissue to its intended target. This capability is ideal for placing central venous catheters (CVC) as clinicians try to quickly gain vascular access while avoiding critical structures.1

In Collaboration With The African Institute of Innovation and Technology

Contact: Lisa Fritzky (425) 951-1375

BOTHELL, WA– April 30, 2012– Sonosite, Inc., the world leader and specialist in bedside and point-of-care ultrasound, today announced a partnership with the African Institute of Innovation and Technology (AIIT), a Kenyan education trust, to establish the first ultrasound education program at Great Lakes University of Kisumu−a technology hub of East Africa. The AIIT ultrasound program is designed to provide physicians, midwives and clinical workers with greater access to ultrasound education, training, and medical resources to improve the health and welfare of the people in the region.

Anil Amlani Appointed as New Chief Financial Officer Effective January 5th

BOTHELL, WA– December 27, 2011– Sonosite, Inc. (Nasdaq:SONO) , the world leader and specialist in bedside and point-of-care ultrasound, today announced that Marcus Smith will resign as Senior Vice President, Chief Financial Officer and Treasurer, effective as of January 2, 2012 and will be leaving the company effective as of January 5, 2012. Anil Amlani, the current President and Chief Executive Officer of Sonosite’s VisualSonics subsidiary, has been appointed the new Chief Financial Officer of Sonosite, effective as of January 2, 2012.

“Anil is a seasoned executive and operator, and is an ideal successor to serve as Sonosite’s new CFO,” said Kevin M. Goodwin, Sonosite’s President and CEO. “For the past 20 years, he has successfully led businesses. He also has served as a Chief Financial Officer for public and non-public companies for 11 years in total. More recently, Anil has led our VisualSonics business before and after the acquisition in June 2010. His broad experience base and global perspective will position Sonosite well.”

New User Interface, Larger Screen Size and Exceptional Image Quality

BOTHELL, WA - December 21, 2011 - Sonosite, Inc. (Nasdaq:SONO) , the world leader and specialist in hand-carried ultrasound for the point-of-care, announced it has received CE Marking (Conformité Européenne) in the European Union to market its next generation point-of-care product: EDGE™ ultrasound system. The EDGE system is currently available for sale in the U.S., following receipt of FDA Premarket Notification 510(k) clearance in November. Sonosite is now commencing international customer deliveries.

Engineered with new state-of-the-art technology, the EDGE ultrasound system takes point-of- care ultrasound to a whole new level of clinical performance and enables physicians to deliver the highest standard of patient care by driving greater efficiencies and the potential for improved outcomes in the hospital and office.

The EDGE ultrasound was formally introduced this fall at medical meetings and congresses in Europe and Australia. Physicians positively responded to the system:

Transaction combines high-quality imaging technologies and pioneering point-of-care expertise to drive next generation medical imaging solutions

Tokyo, Japan / Bothell, WA, U.S. – December 15, 2011 – FUJIFILM Holdings Corporation (TSE: 4901, hereinafter: Fujifilm), a diversified technology company that operates in healthcare, highly functional materials, and document solutions, announced today that it has entered into a definitive agreement with Sonosite, Inc. (NASDAQ: SONO, hereinafter: Sonosite), a pioneer and leader in bedside and point-of-care ultrasound technology, pursuant to which Fujifilm will acquire Sonosite for approximately $995 million (which includes amounts payable in connection with its convertible debt). The transaction was unanimously approved by the Boards of Directors of both companies.